SCHEMBL95160

SCHEMBL95160

O=C(O)CC(O)(C(=O)O)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
HMGCR P04035 1/20 0.50
CHRM1 P11229 1/20 0.50
TBXA2R P21731 1/20 0.50
ADRA1A P35348 1/20 0.50
CYP2C19 P33261 2/20 0.48
HIF1A Q16665 2/20 0.48
TSHR P16473 2/20 0.48
CYP2D6 P10635 1/20 0.48
ACLY P53396 3/20 0.46
CPT2 P23786 2/20 0.44
KDM4E B2RXH2 1/20 0.36
FFAR1 O14842 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27466021 0.97 ALDH1A1 (0.55) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL493898 0.83 ALDH1A1 (0.48) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL2099199 0.83 ALDH1A1 (0.48) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL28576099 0.81 ALDH1A1 (0.46) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL28555973 0.81 ALDH1A1 (0.46) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL7127403 0.81 ALDH1A1 (0.46) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL27554101 0.79 ALDH1A1 (0.44) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL5085109 0.79 ALDH1A1 (0.44) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL6929633 0.75 ALDH1A1 (0.52) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
SCHEMBL21051761 0.75 ALDH1A1 (0.39) ALDH1A1HMGCRCHRM1TBXA2RADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260060977-A1 COMPOSITIONS AND METHODS FOR TREATING PROTOPORPHYRIA UNIV RUTGERS (US) 2026-03-05 US claimed
US-12517271-B2 Radiation detection system and method KROMEK LIMITED (GB) 2026-01-06 US claimed
EP-4237876-B1 RADIATION DETECTION SYSTEM AND METHOD KROMEK LTD (GB) 2025-12-03 EP claimed
US-12487371-B2 Radiation detection system KROMEK LIMITED (GB) 2025-12-02 US claimed
EP-4649157-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF Mojia Biotech Pte. Ltd. (SG) 2025-11-19 EP claimed
CN-118389214-A Acidic fabric care compositions 宝洁公司 2024-07-26 CN claimed
WO-2024150067-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF MOJIA BIOTECH PTE. LTD. (SG) 2024-07-18 WO claimed
CN-113880146-B Positive electrode material precursor, positive electrode material, preparation method and application of positive electrode material precursor and positive electrode material 中国石油化工股份有限公司 2024-03-26 CN claimed
US-11927704-B2 Hybrid radiation detector KROMEK LIMITED (GB) 2024-03-12 US claimed
CN-110914717-B Semiconductor detector geometry 克罗梅克有限公司 2024-01-26 CN claimed
WO-2000036072-A1 BLEACHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-06-22 WO claimed
EP-1010751-A2 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP claimed
EP-1010750-A1 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP claimed
WO-1999002767-A1 A METHOD FOR PRE-FIBRILLATION OF LYOCELL NOVO NORDISK A/S (DK) 1999-01-21 WO claimed
US-5202050-A Method for cleaning hard-surfaces using a composition containing organic solvent and polycarboxylated chelating agent THE PROCTER & GAMBLE COMPANY (US) 1993-04-13 US claimed
EP-0295622-A2 Process for producing L-Tryptophan RESEARCH ASSOCIATION FOR UTILIZATION OF LIGHT OIL (JP) 1988-12-21 EP claimed
EP-0286167-A2 Hard-surface cleaning compositions THE PROCTER & GAMBLE COMPANY (US) 1988-10-12 EP claimed
EP-0024899-B1 PYROPHOSPHATO TITANATE ADDUCTS AND METHODS FOR TREATING PARTICULATE FILLERS USING SUCH ADDUCTS KENRICH PETROCHEMICALS, INC. (US) 1983-08-10 EP claimed
US-3956383-A HEAVY METAL CATALYST HENKEL & CIE G.M.B.H. (DT) 1976-05-11 US claimed
US-3956381-A CARBOXYLATION, 1A METAL ALKYL CARBONATE HENKEL & CIE G.M.B.H. (DT) 1976-05-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060977-A1 COMPOSITIONS AND METHODS FOR TREATING PROTOPORPHYRIA FECH, PPOX, HMBS ALDH1A1 1501/4885HMGCR 1693/4885CHRM1 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.